Applied DNA Sciences Inc (APDN)
3.75
-0.34
(-8.31%)
USD |
NASDAQ |
May 03, 16:00
3.785
+0.04
(+0.93%)
After-Hours: 20:00
Applied DNA Sciences Free Cash Flow: -7.592M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -7.592M |
| September 30, 2023 | -6.296M |
| June 30, 2023 | -7.255M |
| March 31, 2023 | -7.555M |
| December 31, 2022 | -8.043M |
| September 30, 2022 | -9.466M |
| June 30, 2022 | -11.58M |
| March 31, 2022 | -11.50M |
| December 31, 2021 | -15.26M |
| September 30, 2021 | -15.94M |
| June 30, 2021 | -14.31M |
| March 31, 2021 | -15.58M |
| December 31, 2020 | -13.96M |
| September 30, 2020 | -12.21M |
| June 30, 2020 | -9.992M |
| March 31, 2020 | -8.259M |
| December 31, 2019 | -8.095M |
| September 30, 2019 | -6.929M |
| June 30, 2019 | -7.659M |
| March 31, 2019 | -7.566M |
| December 31, 2018 | -6.128M |
| September 30, 2018 | -7.183M |
| June 30, 2018 | -5.626M |
| March 31, 2018 | -6.315M |
| December 31, 2017 | -8.134M |
| Date | Value |
|---|---|
| September 30, 2017 | -7.625M |
| June 30, 2017 | -9.270M |
| March 31, 2017 | -10.09M |
| December 31, 2016 | -10.01M |
| September 30, 2016 | -10.68M |
| June 30, 2016 | -10.01M |
| March 31, 2016 | -8.789M |
| December 31, 2015 | -8.035M |
| September 30, 2015 | -7.604M |
| June 30, 2015 | -7.928M |
| March 31, 2015 | -8.455M |
| December 31, 2014 | -8.802M |
| September 30, 2014 | -8.513M |
| June 30, 2014 | -8.868M |
| March 31, 2014 | -8.850M |
| December 31, 2013 | -8.833M |
| September 30, 2013 | -8.507M |
| June 30, 2013 | -7.000M |
| March 31, 2013 | -6.152M |
| December 31, 2012 | -5.052M |
| September 30, 2012 | -4.124M |
| June 30, 2012 | -4.595M |
| March 31, 2012 | -4.162M |
| December 31, 2011 | -4.103M |
| September 30, 2011 | -3.762M |
Free Cash Flow Range, Past 5 Years
-15.94M
Minimum
Sep 2021
-6.296M
Maximum
Sep 2023
-10.39M
Average
-9.466M
Median
Sep 2022
Free Cash Flow Benchmarks
| Fonar Corp | 12.18M |
| XWELL Inc | -18.45M |
| ProPhase Labs Inc | -14.50M |
| Veracyte Inc | 34.26M |
| OncoCyte Corp | -23.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.758M |
| Cash from Financing (Quarterly) | -0.0351M |
| Free Cash Flow Per Share (Quarterly) | -5.496 |
| Free Cash Flow to Equity (Quarterly) | -3.758M |
| Free Cash Flow to Firm (Quarterly) | -3.758M |
| Free Cash Flow Yield | -305.2% |